Larimar Therapeutics Inc. buy melinda
Start price
14.03.16
/
50%
€64.73
Target price
04.04.16
€81.18
Performance (%)
26.76%
End price
04.04.16
€82.05
Summary
This prediction ended on 04.04.16 with a price of €82.05. The prediction had a final performance of 26.76%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Larimar Therapeutics Inc. | -6.154% | -6.154% | -19.205% | -57.565% |
| iShares Core DAX® | 0,61 % | 0,34 % | 12,06 % | 58,10 % |
| iShares Nasdaq 100 | 0,64 % | -3,17 % | 1,74 % | 84,36 % |
| iShares Nikkei 225® | -0,13 % | 8,92 % | 27,39 % | 64,84 % |
| iShares S&P 500 | 0,54 % | -0,70 % | 1,91 % | 58,67 % |
According to melinda what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Zafgen Inc. diskutieren
obesité sévére
données le 31/03/2016
Stopped prediction by melinda for Larimar Therapeutics Inc.
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.94
10.12.19
10.12.19
€13.00
04.11.21
04.11.21
20.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€54.88
07.02.19
07.02.19
€97.42
13.02.19
13.02.19
-11.83%
13.02.19
13.02.19
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€87.46
08.03.18
08.03.18
€97.42
25.06.18
25.06.18
16.58%
25.06.18
25.06.18
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€44.92
13.05.17
13.05.17
€54.12
14.11.17
14.11.17
-12.05%
14.11.17
14.11.17
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€78.15
07.04.16
07.04.16
€184.01
21.07.16
21.07.16
-54.46%
21.07.16
21.07.16
Could be worthwhile Investment >10% per year